Acute Leukemias - When Blasts Go Bad
- Sudden onset; bone marrow failure (anemia, infections, bleeding).
- Defined by >20% blasts in bone marrow or blood.
-
Acute Myeloid Leukemia (AML)
- Affects older adults (~65 years).
- Myeloblasts with Auer rods (pathognomonic).
- 📌 Auer rods for Myeloid Leukemia.
-
Acute Lymphoblastic Leukemia (ALL)
- Most common childhood cancer.
- Lymphoblasts are TdT+.
- Requires CNS prophylaxis.

⭐ Acute Promyelocytic Leukemia (APL), an AML subtype with t(15;17) translocation, is uniquely treated with all-trans-retinoic acid (ATRA), which induces differentiation of blasts.
ALL - Lymphoid Lineage Gone Wild
- Malignant, clonal proliferation of lymphoid blasts (>20% in bone marrow). It's the most common cancer of childhood (peak age 2-5 years) and is associated with Down syndrome.
- Hallmark Markers: Blasts are TdT+ (terminal deoxynucleotidyl transferase), a marker of immature lymphocytes. Cytoplasm often contains PAS+ aggregates.

- Subtypes & Prognosis
- B-ALL: Most common. Good prognosis associated with t(12;21). Poor prognosis with t(9;22) [Philadelphia chromosome].
- T-ALL: Less common, presents in adolescents.
⭐ T-ALL classically presents as a large anterior mediastinal (thymic) mass in a teenager, potentially causing Superior Vena Cava (SVC) syndrome or dysphagia.
📌 Remember ALL the children.
AML - Myeloid Mayhem
- Malignant proliferation of myeloblasts (>20% in bone marrow). Primarily affects older adults (median age 65).
- Presentation: Pancytopenia symptoms-anemia (fatigue), thrombocytopenia (bleeding), neutropenia (infections). Gingival hyperplasia is also characteristic.
- Microscopy: Large blasts with punched-out nucleoli.
- Auer rods: Pathognomonic needle-like, reddish-pink cytoplasmic inclusions.

- Auer rods: Pathognomonic needle-like, reddish-pink cytoplasmic inclusions.
- Key Subtypes & Genetics:
- APL (Acute Promyelocytic Leukemia): t(15;17) PML-RARα fusion gene.
- Associated with DIC.
- Treatment: All-trans-retinoic acid (ATRA) induces differentiation.
- t(8;21): Favorable prognosis.
- inv(16): Favorable prognosis.
- APL (Acute Promyelocytic Leukemia): t(15;17) PML-RARα fusion gene.
- 📌 Mnemonic: "All Myeloblasts Look alike."
⭐ Acute Promyelocytic Leukemia (APL, M3 subtype) is a medical emergency due to high risk of disseminated intravascular coagulation (DIC) from granule release. Treatment with ATRA can rapidly resolve this.
Lab Lowdown - Telling Blasts Apart
- Myeloblasts: Large size, fine chromatin, prominent nucleoli, cytoplasmic granules.
- Auer Rods: Pathognomonic needle-like inclusions.
- Lymphoblasts: Scant agranular cytoplasm, condensed chromatin, inconspicuous nucleoli.
⭐ T-ALL can present as a mediastinal (thymic) mass in a teenager, potentially causing SVC syndrome or dysphagia.
📌 Mnemonic: T-cell markers for T-ALL (CD2-8). Think Be-TEN-NINETEEN-TWENTY for B-ALL (CD10, CD19, CD20).
High‑Yield Points - ⚡ Biggest Takeaways
- Acute leukemias are defined by >20% blasts in the bone marrow, causing an abrupt onset of pancytopenia (fatigue, bleeding, infections).
- ALL is the most common cancer in children; blasts are TdT+. The t(12;21) translocation carries a good prognosis.
- AML primarily affects older adults (~65 years); blasts are MPO+ and may contain pathognomonic Auer rods.
- APL (M3), an AML subtype with t(15;17), is a medical emergency treated with all-trans retinoic acid (ATRA).
- The Philadelphia chromosome t(9;22) confers a poor prognosis in both ALL and AML.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app